ImaRx’ Combo Treatment For Stroke To Wrap Up Phase I/II Trial By Mid-2008
This article was originally published in The Gray Sheet
Executive Summary
ImaRx is on track to complete enrollment in a Phase I/II dose escalation study by mid-2008 for its combo product SonoLysis, which uses ultrasound and microbubbles to treat acute ischemic stroke